74 related articles for article (PubMed ID: 18536235)
1. [Treatment recommendations of chronic hepatitis B. Did the world escape us?].
Flisiak R; Jaroszewicz J
Przegl Epidemiol; 2008; 62(1):133-8. PubMed ID: 18536235
[TBL] [Abstract][Full Text] [Related]
2. Non-interventional study AI463-12 of real-world chronic HBV infection management--baseline characteristics and treatment patterns of Polish patients kohort.
Simon K; Błudzin W; Dziambor A; Goryszewski D; Postawa-Kłosińska B; Sieklucki J; Kolasa K; Lescrauwaet B
Przegl Epidemiol; 2013; 67(4):617-21, 709-12. PubMed ID: 24741906
[TBL] [Abstract][Full Text] [Related]
3. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
Lindh M; Uhnoo I; Bläckberg J; Duberg AS; Friman S; Fischler B; Karlström O; Norkrans G; Reichard O; Sangfeldt P; Söderström A; Sönnerborg A; Weiland O; Wejstål R; Wiström J
Scand J Infect Dis; 2008; 40(6-7):436-50. PubMed ID: 18584530
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy of patients affected by HBeAg-negative chronic hepatitis B.
Marcellin P; Boyer N; Asselah T
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):23-38. PubMed ID: 16554704
[TBL] [Abstract][Full Text] [Related]
6. Antiviral options for the treatment of chronic hepatitis B.
Osborn MK; Lok AS
J Antimicrob Chemother; 2006 Jun; 57(6):1030-4. PubMed ID: 16595637
[TBL] [Abstract][Full Text] [Related]
7. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
Buster EH; Janssen HL
Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B: a wider range of therapeutic options.
Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of hepatitis B virus infection].
Trautwein C
Praxis (Bern 1994); 2006 Sep; 95(36):1389-97. PubMed ID: 16989182
[TBL] [Abstract][Full Text] [Related]
10. [Management of chronic hepatitis B in treatment-naive patients].
Cheong JY
Korean J Gastroenterol; 2008 Jun; 51(6):338-45. PubMed ID: 18604135
[TBL] [Abstract][Full Text] [Related]
11. [Protocol for the antiviral therapy of chronic hepatitis B].
;
Orv Hetil; 2008 Dec; 149(49):2341-3. PubMed ID: 19042187
[No Abstract] [Full Text] [Related]
12. Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
Cooksley WG
Semin Liver Dis; 2004; 24 Suppl 1():45-53. PubMed ID: 15192801
[TBL] [Abstract][Full Text] [Related]
13. [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations].
Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Malkowski P; Pawlowska M; Simon K;
Pol Merkur Lekarski; 2010 Aug; 29(170):103-6. PubMed ID: 20842822
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.
Peng H; Liu J; Yang M; Tong S; Yin W; Tang H; Hu P; Hu H; Ren H
J Clin Pharmacol; 2014 Feb; 54(2):189-200. PubMed ID: 24105676
[TBL] [Abstract][Full Text] [Related]
15. The maze of treatments for hepatitis B.
Lok AS
N Engl J Med; 2005 Jun; 352(26):2743-6. PubMed ID: 15987924
[No Abstract] [Full Text] [Related]
16. Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
Shim JH; Suh DJ; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Hepatology; 2009 Oct; 50(4):1064-71. PubMed ID: 19637288
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.
Liaw YF; Raptopoulou-Gigi M; Cheinquer H; Sarin SK; Tanwandee T; Leung N; Peng CY; Myers RP; Brown RS; Jeffers L; Tsai N; Bialkowska J; Tang S; Beebe S; Cooney E
Hepatology; 2011 Jul; 54(1):91-100. PubMed ID: 21503940
[TBL] [Abstract][Full Text] [Related]
18. Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
Colle I; Adler M; Brenard R; Henrion J; Langlet P; Michielsen P; Orlent H; Reynaert H; Sprengers D; Stärkel P; Van Damme P; Verslype C; Delwaide J;
Acta Gastroenterol Belg; 2007; 70(4):389-420. PubMed ID: 18330099
[No Abstract] [Full Text] [Related]
19. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.
Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1315-41; quiz 1286. PubMed ID: 18845489
[TBL] [Abstract][Full Text] [Related]
20. [Treatment has a positive impact on the long-term evolution of chronic hepatitis B].
Marcellin P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S99-102. PubMed ID: 21095519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
